Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA DIVIS LABORATORIES JUBILANT PHARMOVA /
DIVIS LABORATORIES
 
P/E (TTM) x -2,655.4 67.3 - View Chart
P/BV x 1.7 7.3 23.1% View Chart
Dividend Yield % 0.9 0.9 102.5%  

Financials

 JUBILANT PHARMOVA    DIVIS LABORATORIES
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
DIVIS LABORATORIES
Mar-23
JUBILANT PHARMOVA /
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4964,641 10.7%   
Low Rs2692,730 9.8%   
Sales per share (Unadj.) Rs394.4292.6 134.8%  
Earnings per share (Unadj.) Rs-4.168.7 -5.9%  
Cash flow per share (Unadj.) Rs30.781.6 37.6%  
Dividends per share (Unadj.) Rs5.0030.00 16.7%  
Avg Dividend yield %1.30.8 160.7%  
Book value per share (Unadj.) Rs338.6480.9 70.4%  
Shares outstanding (eoy) m159.28265.47 60.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.012.6 7.7%   
Avg P/E ratio x-93.853.7 -174.9%  
P/CF ratio (eoy) x12.445.2 27.6%  
Price / Book Value ratio x1.17.7 14.7%  
Dividend payout %-122.743.7 -281.0%   
Avg Mkt Cap Rs m60,873978,378 6.2%   
No. of employees `000NANA-   
Total wages/salary Rs m21,6609,750 222.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m62,81777,675 80.9%  
Other income Rs m3833,447 11.1%   
Total revenues Rs m63,20181,122 77.9%   
Gross profit Rs m7,31723,691 30.9%  
Depreciation Rs m5,5403,432 161.4%   
Interest Rs m1,88220 9,601.8%   
Profit before tax Rs m27823,686 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9275,453 17.0%   
Profit after tax Rs m-64918,234 -3.6%  
Gross profit margin %11.630.5 38.2%  
Effective tax rate %333.523.0 1,449.0%   
Net profit margin %-1.023.5 -4.4%  
BALANCE SHEET DATA
Current assets Rs m37,62497,437 38.6%   
Current liabilities Rs m17,72415,331 115.6%   
Net working cap to sales %31.7105.7 30.0%  
Current ratio x2.16.4 33.4%  
Inventory Days Days258 292.7%  
Debtors Days Days56842 6.6%  
Net fixed assets Rs m71,66851,128 140.2%   
Share capital Rs m159531 30.0%   
"Free" reserves Rs m53,772127,140 42.3%   
Net worth Rs m53,931127,671 42.2%   
Long term debt Rs m31,1040-   
Total assets Rs m109,292148,565 73.6%  
Interest coverage x1.11,209.5 0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.60.5 109.9%   
Return on assets %1.112.3 9.2%  
Return on equity %-1.214.3 -8.4%  
Return on capital %2.518.6 13.7%  
Exports to sales %085.7 0.0%   
Imports to sales %4.119.8 20.6%   
Exports (fob) Rs mNA66,537 0.0%   
Imports (cif) Rs m2,56415,378 16.7%   
Fx inflow Rs m7,10066,537 10.7%   
Fx outflow Rs m2,56415,715 16.3%   
Net fx Rs m4,53650,822 8.9%   
CASH FLOW
From Operations Rs m6,60724,597 26.9%  
From Investments Rs m-5,444-27,076 20.1%  
From Financial Activity Rs m-1,567-7,972 19.7%  
Net Cashflow Rs m301-10,451 -2.9%  

Share Holding

Indian Promoters % 47.4 51.9 91.3%  
Foreign collaborators % 3.3 0.0 -  
Indian inst/Mut Fund % 23.2 36.7 63.1%  
FIIs % 20.3 14.9 136.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 48.1 102.6%  
Shareholders   86,588 354,482 24.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUPRIYA LIFESCIENCE     


More on Jubilant Pharmova vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Jubilant Pharmova vs Divis Laboratories Share Price Performance

Period Jubilant Pharmova Divis Laboratories S&P BSE HEALTHCARE
1-Day 0.53% 0.55% 0.88%
1-Month -5.96% -5.87% -4.09%
1-Year 89.10% 25.22% 59.00%
3-Year CAGR -7.57% 2.33% 18.97%
5-Year CAGR -8.18% 15.69% 19.20%

* Compound Annual Growth Rate

Here are more details on the Jubilant Pharmova share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of Jubilant Pharmova hold a 50.7% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Jubilant Pharmova and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, Jubilant Pharmova paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of -122.7%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of Jubilant Pharmova, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.